Response to: 'Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis' by Bugatti <i>et al</i>.

Studenic, Paul; Felson, David T; de Wit, Maarten; Smolen, Josef S; Aletaha, Daniel

Response to: 'Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis' by Bugatti et al.

Studenic, Paul; Felson, David T; de Wit, Maarten; Smolen, Josef S; Aletaha, Daniel.

Afiliação

Studenic P; Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Wien, Austria.
Felson DT; Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA.
de Wit M; Centre for Epidemiology, The University of Manchester, Manchester, UK.
Smolen JS; Standing Committee of People with Arthritis/Rheumatism in Europe (PARE), EULAR, Zurich, Switzerland.
Aletaha D; Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Wien, Austria.

Ann Rheum Dis ; 81(4): e56, 2022 04.

Article em En | MEDLINE | ID: mdl-32398283

Assuntos

Antirreumáticos; Artrite Reumatoide; Antirreumáticos/uso terapêutico; Artrite Reumatoide/diagnóstico; Artrite Reumatoide/tratamento farmacológico; Humanos

Palavras-chave

arthritis; health care; outcome assessment; patient reported outcome measures; rheumatoid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google